Live events are available to Redeye members
Sign up for a free membership
Already a member?
Sign in
Live stream at Redeye.se/events
ALZECURE UPDATE ON PROGRESS IN THEIR PAINLESS PLATFORM
Welcome to a Redeye event where AlzeCure will give a presentation on its project platform Painless and the progress made, with recent positive clinical results from the ACD440 phase Ib trial for neuropathic pain and advancements made in the TrkA-NAM pain project, projects that complement AlzeCure’s broad Alzheimer’s portfolio.
Presenting will be Martin Jönsson, CEO, Märta Segerdahl, CMO, Pontus Forsell, Head of Discovery & Research and Johan Sandin, CSO. The event will include a Q&A session and discussion led by Anders Hedlund, analyst at Redeye.
This event will be presented in English
NOTE
Companies and schedules may change before the event starts. Save the date to your calendar by using Add to calendar.